Floatz logo

cg-0255 besylate

Recent Myocardial Infarction

Shanghai CureGene Pharmaceutical Co., Ltd.Phase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Recent Myocardial Infarction cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
Shanghai CureGene Pharmaceutical Co., Ltd.
Phase 4A
Plavix
Shanghai CureGene Pharmaceutical Co., Ltd.
Phase 4A
Ticagrelor
Assistance Publique - Hôpitaux de Paris
Phase 4BBB
Folic Acid
Hamilton Health Sciences Corporation
Phase 4BBB
Vitamin B6
Hamilton Health Sciences Corporation
Phase 4BBB

View all 37 →

Same molecule, other indications

cg-0255 besylate is also rated in:

acute coronary syndromeDormant
CC
Indicative ·
43 / 100
View asset →
stroke disorderDormant
CC
Indicative ·
43 / 100
View asset →
peripheral arterial diseaseDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →